SKI2852 is an Orally Active 11β-HSD1 Inhibitor for Metabolic Disease Research
Type 2 diabetes (T2D) is a chronic health condition that has reached alarming rates across the globe. The International Diabetes Federation (IDF) published the Diabetes Atlas, which estimated that 463…